Catheter ablation in patients with atrial fibrillation : mapping refinements, outcome prediction and effect on quality of life

PhD ThesisChapter 1 presents a literature review, focused primarily on the pathophysiology and management of atrial fibrillation (AF). Chapter 2 examines correlations between the dominant frequency of AF - calculated using principal component analysis from a modified surface 12-lead ECG (which included posterior leads), a standard 12-lead ECG and intracardiac recordings from both atria. The inclusion of posterior leads did not improve correlation with left atrial activity because of the dominance of lead V1 in both ECG configurations. Chapter 3 explores whether acute and 12-month outcome following catheter ablation for AF can be predicted beforehand from clinical and surface AF waveform parameters. Multivariate risk scores combining these parameters can predict arrhythmia outcome following ablation, and could therefore be used to identify those most likely to benefit from this therapy. Chapter 4 examines the effect of catheter ablation on AF symptoms and quality of life (QoL). AF symptom and QoL scores improved significantly in patients who maintained sinus rhythm after ablation but did not change in those with recurrent AF. AF-specific QoL scales are more responsive to change and correlate better with ablation outcome. Chapter 5 examines inter-atrial frequency gradients in patients with persistent AF using multipolar contact mapping. A right-to-left atrial frequency gradient was found in a quarter of the patients studied, implying that their arrhythmia was being maintained by high frequency sources in the right rather than the left atrium. Chapter 6 examines whether targeting high frequency and highly repetitive complex fractionated atrial electrogram sites, identified using multipolar contact mapping during persistent AF, resulted in arrhythmia termination and maintenance of sinus rhythm long-term. The utility of administering flecainide to distinguish critical from bystander AF sites was also investigated. Flecainide did not help refine ablation targets and 12-month outcome after targeting these sites was not superior to other ablation strategies

Right Ventricular Outflow Tract Arrhythmias : Benign Or Early Stage Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia?

Ventricular arrhythmias (VAs) arising from the right ventricular outflow tract (RVOT) are a common and heterogeneous entity. Idiopathic right ventricular arrhythmias (IdioVAs) are generally benign, with excellent ablation outcomes and long-term arrhythmia-free survival, and must be distinguished from other conditions associated with VAs arising from the right ventricle: the differential diagnosis with arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) is therefore crucial because VAs are one of the most important causes of sudden cardiac death (SCD) in young individuals even with early stage of the disease. Radiofrequency catheter ablation (RFCA) is a current option for the treatment of VAs but important differences must be considered in terms of indication, purposes and procedural strategies in the treatment of the two conditions. In this review, we comprehensively discuss clinical and electrophysiological features, diagnostic and therapeutic techniques in a compared analysis of these two entities

Comparison of epicardial mapping and noncontact endocardial mapping in dog experiments and computer simulations

La fibrillation auriculaire, l'arythmie la plus fréquente en clinique, affecte 2.3 millions de patients en Amérique du Nord. Pour en étudier les mécanismes et les thérapies potentielles, des modèles animaux de fibrillation auriculaire ont été développés. La cartographie électrique épicardique à haute densité est une technique expérimentale bien établie pour suivre in vivo l'activité des oreillettes en réponse à une stimulation électrique, à du remodelage, à des arythmies ou à une modulation du système nerveux autonome. Dans les régions qui ne sont pas accessibles par cartographie épicardique, la cartographie endocardique sans contact réalisée à l'aide d'un cathéter en forme de ballon pourrait apporter une description plus complète de l'activité auriculaire. Dans cette étude, une expérience chez le chien a été conçue et analysée. Une reconstruction électro-anatomique, une cartographie épicardique (103 électrodes), une cartographie endocardique sans contact (2048 électrodes virtuelles calculées à partir un cathéter en forme de ballon avec 64 canaux) et des enregistrements endocardiques avec contact direct ont été réalisés simultanément. Les systèmes d'enregistrement ont été également simulés dans un modèle mathématique d'une oreillette droite de chien. Dans les simulations et les expériences (après la suppression du nœud atrio-ventriculaire), des cartes d'activation ont été calculées pendant le rythme sinusal. La repolarisation a été évaluée en mesurant l'aire sous l'onde T auriculaire (ATa) qui est un marqueur de gradient de repolarisation. Les résultats montrent un coefficient de corrélation épicardique-endocardique de 0.8 (expérience) and 0.96 (simulation) entre les cartes d'activation, et un coefficient de corrélation de 0.57 (expérience) and 0.92 (simulation) entre les valeurs de ATa. La cartographie endocardique sans contact apparait comme un instrument expérimental utile pour extraire de l'information en dehors des régions couvertes par les plaques d'enregistrement épicardique.Atrial fibrillation is the most common clinical arrhythmia currently affecting 2.3 million patients in North America. To study its mechanisms and potential therapies, animal models of atrial fibrillation have been developed. Epicardial high-density electrical mapping is a well-established experimental instrument to monitor in vivo the activity of the atria in response to pacing, remodeling, arrhythmias and modulation of the autonomic nervous system. In regions that are not accessible by epicardial mapping, noncontact endocardial mapping performed through a balloon catheter may provide a more comprehensive description of atrial activity. In this study, a dog experiment was designed and analyzed in which electroanatomical reconstruction, epicardial mapping (103 electrodes), noncontact endocardial mapping (2048 virtual electrodes computed from a 64-channel balloon catheter), and direct-contact endocardial catheter recordings were simultaneously performed. The recording system was also simulated in a computer model of the canine right atrium. For simulations and experiments (after atrio-ventricular node suppression), activation maps were computed during sinus rhythm. Repolarization was assessed by measuring the area under the atrial T wave (ATa), a marker of repolarization gradients. Results showed an epicardial endocardial correlation coefficient of 0.8 (experiment) and 0.96 (simulation) between activation times, and a correlation coefficient of 0.57 (experiment) and 0.92 (simulation) between ATa values. Noncontact mapping appears to be a valuable experimental device to retrieve information outside the regions covered by epicardial recording plaques

Automated algorithm-driven methods of localising drivers of persistent atrial fibrillation using atrial fibrillation cycle length and atrial fibrillation voltage

The assessment of atrial fibrillation cycle length has played a role in the development of atrial fibrillation ablation by pulmonary vein isolation (PVI) and has also been used to assess response to ablation. Areas of rapid rotational activity in the left atrium have been implied to act as drivers of persistent atrial fibrillation and several methods have been developed to identify these potential drivers. Unprocessed atrial fibrillation electrograms show large variation in cycle length and signal amplitude. Current methods of localising driver regions rely on complex pattern recognition and subjective assessment of operators. The main hypotheses of this thesis were as follows: 1) a technique can be developed to ascertain a clinically relevant, dominant cycle length for any AF segment, 2) the automated technique, can be used to map rapid and regular activity in the left atrium, 3) a patient-tailored definition of rapid activity and low AF voltage, calculated based on patient-specific parameters is feasible; 4) paired with automated low voltage substrate analysis, dominant cycle length analysis is able to provide a framework for localising drivers of AF that is objective, transparent and requires no complex pattern recognition of subjective judgement. To test the hypotheses, a technique was developed based on manual annotation of real-world AF electrograms that was able to ascertain cycle length independent of missing segments or variable cycle length or signal amplitude. Following this, an automated algorithm was validated to determine dominant cycle length. In the following chapter, the nature of AF cycle length was investigated by investigating the patterns of rapid activity with extended AF segments and the concept of patient-tailored definitions of rapid activity was introduced. In the subsequent analysis, the effect of PVI was examined on AF voltage and the AF cycle length, focusing on rapid and regular areas and low voltage zones, and their changes. The last chapter utilised the accumulated information to test the sensitivity and specificity of a percentile-based, patient-tailored approach to low AF voltage and to present an objective, automated method of localising rapid and regular areas within low voltage zones within the left atrium. In summary, it is feasible to assess and locate rapid and regular areas, and localise low voltage zones in persistent AF with a completely automated algorithm, and patient-tailored definitions of low voltage rapid AF activity are a preferable alternative to absolute cut offs.Open Acces

Multichannel Analysis of Intracardiac Electrograms - Supporting Diagnosis and Treatment of Cardiac Arrhythmias

Cardiologists diagnose and treat atrial tachycardias using electroanatomical mapping systems. These can be combined with multipolar catheters to record intracardiac electrograms. Within this thesis, various signal processing techniques were implemented and benchmarked to analyze electrograms. They support the physician in diagnosis and treatment of atrial flutter and atrial fibrillation. The developed methods were assessed using simulated data and demonstrated on clinical cases

Contributions To The Methodology Of Electrocardiographic Imaging (ECGI) And Application Of ECGI To Study Mechanisms Of Atrial Arrhythmia, Post Myocardial Infarction Electrophysiological Substrate, And Ventricular Tachycardia In Patients

ABSTRACT OF THE DISSERTATION Contributions to the Methodology of Electrocardiographic Imaging: ECGI) and Application of ECGI to Study Mechanisms of Atrial Arrhythmia, Post Myocardial Infarction Electrophysiological Substrate, and Ventricular Tachycardia in Patients by Yong Wang Doctor of Philosophy in Biomedical Engineering Washington University in St. Louis, 2009 Professor Yoram Rudy, Chair Electrocardiographic Imaging: ECGI) is a noninvasive imaging modality for cardiac electrophysiology and arrhythmia. ECGI reconstructs epicardial potentials, electrograms and isochrones from body-surface electrocardiograms combined with heart-torso geometry from computed tomography: CT). The application of a new meshless method, the Method of Fundamental Solutions: MFS) is introduced to ECGI with the following major advantages: 1. Elimination of meshing and manual mesh optimization processes, thereby enhancing automation and speeding the ECGI procedure. 2. Elimination of mesh-induced artifacts. 3. Simpler implementation. These properties of MFS enhance the practical application of ECGI as a clinical diagnostic tool. The current ECGI mode of operation is offline with generation of epicardial potential maps delayed to data acquisition. A real time ECGI procedure is proposed, by which the epicardial potentials can be reconstructed while the body surface potential data are acquired: \u3c 1msec/frame) during a clinical procedure. This development enables real-time monitoring, diagnosis, and interactive guidance of intervention for arrhythmia therapy. ECGI is applied to map noninvasively the electrophysiological substrate in eight post-MI patients during sinus rhythm: SR). Contrast-enhanced MRI: ceMRI) is conducted to determine anatomical scar. ECGI imaged regions of electrical scar corresponded closely in location, extent, and morphology to the anatomical scars. In three patients, late diastolic potentials are imaged in the scar epicardial border zone during SR. Scar-related ventricular tachycardia: VT) in two patients are imaged, showing the VT activation sequence in relation to the abnormal electrophysiological substrate. ECGI imaging the substrate in a beat-by-beat fashion could potentially help in noninvasive risk stratification for post-MI arrhythmias and facilitate substrate-based catheter ablation of these arrhythmias. ECGI is applied to eleven consecutive patients referred for VT catheter ablation procedure. ECGI is performed either before: 8 patients) or during: 3 patients) the ablation procedure. Blinded ECGI and invasive electrophysiology: EP) study results are compared. Over a wide range of VT types and locations, ECGI results are consistent with EP data regarding localization of the arrhythmia origin: including myocardial depth) and mechanism: focal, reentrant, fascicular). ECGI also provides mechanistic electrophysiological insights, relating arrhythmia patterns to the myocardial substrate. The study shows ECGI has unique potential clinical advantages, especially for hemodynamically intolerant VT or VT that is difficult to induce. Because it provides local cardiac information, ECGI may aid in better understanding of mechanisms of ventricular arrhythmia. Further prospective trials of ECGI with clinical endpoints are warranted. Many mechanisms for the initiation and perpetuation of atrial fibrillation: AF) have been demonstrated over the last several decades. The tools to study these mechanisms in humans have limitations, the most common being invasiveness of a mapping procedure. In this paper, we present simultaneous noninvasive biatrial epicardial activation sequences of AF in humans, obtained using the Electrocardiographic Imaging: ECGI) system, and analyzed in terms of mechanisms and complexity of activation patterns. We performed ECGI in 36 patients with a diagnosis of AF. To determine ECGI atrial accuracy, atrial pacing from different sites was performed in six patients: 37 pacing events), and ECGI was compared to registered CARTO images. Then, ECGI was performed on all 36 patients during AF and ECGI epicardial maps were analyzed for mechanisms and complexity. ECGI noninvasively imaged the low-amplitude signals of AF in a wide range of patients: 97% procedural success). The spatial accuracy in determining initiation sites as simulated by atrial pacing was ~ 6mm. ECGI imaged many activation patterns of AF, most commonly multiple wavelets: 92%), with pulmonary vein: 69%) and non-pulmonary vein: 62%) trigger sites. Rotor activity was seen rarely: 15%). AF complexity increased with longer clinical history of AF, though the degree of complexity of nonparoxysmal AF varied and overlapped. ECGI offers a way to identify unique epicardial activation patterns of AF in a patient-specific manner. The results are consistent with contemporary animal models of AF mechanisms and highlight the coexistence of a variety of mechanisms among patients

Mapping Technologies for Catheter Ablation of Atrial Fibrillation Beyond Pulmonary Vein Isolation

Catheter ablation remains the most effective and relatively minimally invasive therapy for rhythm control in patients with AF. Ablation has consistently shown a reduction of arrhythmia-related symptoms and significant improvement in patients’ quality of life compared with medical treatment. The ablation strategy relies on a well-established anatomical approach of effective pulmonary vein isolation. Additional anatomical targets have been reported with the aim of increasing procedure success in complex substrates. However, larger ablated areas with uncertainty of targeting relevant regions for AF initiation or maintenance are not exempt from the potential risk of complications and pro-arrhythmia. Recent developments in mapping tools and computational methods for advanced signal processing during AF have reported novel strategies to identify atrial regions associated with AF maintenance. These novel tools – although mainly limited to research series – represent a significant step forward towards the understanding of complex patterns of propagation during AF and the potential achievement of patient-tailored AF ablation strategies for the near future

Doctor of Philosophy

dissertationAtrial fibrillation (AF) is the leading cause of ischemic stroke and is the most commonly observed arrhythmia in clinical cardiology. Catheter ablation of AF, in which specific regions of cardiac anatomy associated with AF are intenionally injured to create scar tissue, has been honed over the last 15 years to become a relatively common and safe treatment option. However, the success of these anatomically driven ablation strategies, particularly in hearts that have been exposed to AF for extended periods, remains poor. AF induces changes in the electrical and structural properties of the cardiac tissue that further promotes the permanence of AF. In a process known as electroanatomical (EAM) mapping, clinicians record time signals known as electrograms (EGMs) from the heart and the locations of the recording sites to create geometric representations, or maps, of the electrophysiological properties of the heart. Analysis of the maps and the individual EGM morphologies can indicate regions of abnormal tissue, or substrates that facilitate arrhythmogenesis and AF perpetuation. Despite this progress, limitations in the control of devices currently used for EAM acquisition and reliance on suboptimal metrics of tissue viability appear to be hindering the potential of treatment guided by substrate mapping. In this research, we used computational models of cardiac excitation to evaluate param- eters of EAM that affect the performance of substrate mapping. These models, which have been validated with experimental and clinical studies, have yielded new insights into the limitations of current mapping systems, but more importantly, they guided us to develop new systems and metrics for robust substrate mapping. We report here on the progress in these simulation studies and on novel measurement approaches that have the potential to improve the robustness and precision of EAM in patients with arrhythmias. Appropriate detection of proarrhythmic substrates promises to improve ablation of AF beyond rudimentary destruction of anatomical targets to directed targeting of complicit tissues. Targeted treatment of AF sustaining tissues, based on the substrate mapping approaches described in this dissertation, has the potential to improve upon the efficacy of current AF treatment options